MedTrace Logo

CTHRC1 Abiomarker in Rheumatoid Arthritis Diagnosis

NCT04085471 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2019-09-18

No results posted yet for this study

Summary

The purpose of the study is to determine whether plasma levels of the collagen triple helix repeat containing (CTHRC1) protein can serve as a blood-based biomarker for diagnosis of rheumatoid arthritis (RA) ,and furthermore its correlation with disease activity.

Conditions

Interventions

DIAGNOSTIC_TEST

CTHRC1 biomarker level in rheumatoid arthritis

measurment of levels of CTHRC1 in patients diagnosed as RA

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2020-10-01
Completion
2020-12-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04085471 on ClinicalTrials.gov